Target intelligence / Profile preview

Synovial fluid components

Molecular classification
Other
01

Overview

Synovial fluid is a viscous liquid found within synovial joint cavities responsible for joint lubrication, nutrient delivery, and modulation of inflammation. It is a non-Newtonian fluid composed mainly of hyaluronic acid, lubricin (proteoglycan 4), proteins (including enzymes and cytokines), immune cell-derived extracellular vesicles, and small amounts of nutrients. Its primary biological functions are to lubricate cartilage surfaces for frictionless movement, nourish articular cartilage, and modulate joint immune response. Pathological changes in its composition and volume are associated with inflammatory joint diseases including osteoarthritis and rheumatoid arthritis. Analysis of synovial fluid is commonly used for disease diagnosis, monitoring, and biomarker discovery. However, "synovial fluid components" refers to a mixture rather than a specific molecular target, so it is not a canonical therapeutic target like a receptor, enzyme, or transporter. Instead, individual components (e.g., hyaluronic acid, cytokines, lubricin) are considered distinct molecular targets in drug development and diagnostics. The term "Synovial fluid components" is not a canonical target, but an umbrella term for multiple molecules with separate clinical and therapeutic significance. For structured target information, specify the exact molecule (e.g., "Hyaluronic acid," "Lubricin," "Interleukin-6") to generate actionable data for drug discovery or biomarker use.

Other names
SynoviaJoint fluid component
02

Mechanism of action

null (mechanisms target individual molecules like hyaluronic acid, not the generic fluid)

03

Biological functions

Lubrication of joint surfacesNutrient transport to cartilageRemoval of cellular debrisModulation of inflammationProtection against wear and tear
04

Disease associations

Inflammation (arthritis, rheumatoid arthritis, osteoarthritis)Joint degeneration
05

Safety considerations

null (safety concerns are associated with altered fluid composition, not the mixture itself)
06

Interacting drugs

null (drugs interact with specific synovial fluid components, not the mixture itself)
07

Biomarkers

Individual constituents are biomarkers, e.g., hyaluronic acid levels, cytokine levels

Beyond the preview

Go deeper on Synovial fluid components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovial fluid components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call